Aemetis: Q3 Earnings Snapshot

Aemetis Inc. (AMTX) reported Q3 net income of $5.2M, reversing a year-earlier loss. Earnings per share of -$0.02 beat estimates of -$0.20. Revenue was $88.2M, exceeding forecasts of $69.7M. Shares closed at $1.25, down from $2.06 a year ago.

Original reporting
Published Nov 5, 2026, 1:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 1:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aemetis: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$AMTXBullishMed
01

Why it matters

The earnings surprise was modest and the share price decline suggests market skepticism.

02

Market read

Microcap earnings with a significant price move; relevant for short-term traders in the renewable sector.

03

What to watch

Potential impact of upcoming policy incentives for renewable fuels not reflected in current price.

Relevance 6/10Novelty 7/10Timing: after-hours

Background

Aemetis Inc. reported Q3 results that exceeded analyst estimates, but the stock fell sharply.

Company-level read

Ticker impact

$AMTXBullishHigh confidence
Context

Q3 earnings beat expectations with $5.2M net income and $88.2M revenue, shares fell to $1.25 from $2.06.

Expected impact

likely further downside as investors reassess guidance and valuation.

Evidence & confidence

The surprise profit was modest and the stock price already fell 40% YoY, suggesting weak momentum.

Market effects

Renewable fuels sector may see modest pressure as earnings miss growth expectations.

Limited to U.S. small-cap investors; no broader market effect.

Low global relevance beyond niche renewable chemicals investors.

Counterpoint

Despite the price drop, the earnings beat could signal a turnaround if the company secures new contracts.

Key entities

  • Aemetis Inc.

    Renewable fuels and specialty chemicals producer.

Related articles

$AMTXMed

Aemetis Reports Third Quarter 2026 Financial Results

AEMETIS, INC (AMTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Aemetis Reports Third Quarter 2026 Financial Results Net Income of $5.2 million, Revenue Growth of 49%, Adjusted EBITDA of $24.8 million • Revenues of $88.2 million, an increase of $29.0 million (49%) over the third quarter of 2025 • Aemetis Biogas RNG sales volume g

$AMTXMedAI 8/10

Aemetis (AMTX) Q2 2026 Earnings Call Transcript

Aemetis (AMTX) reported Q2 2026 revenue of $62.7M, up 20% YoY, with operating income of $5.8M, reversing a prior-year loss. Growth was driven by ethanol and renewable natural gas segments. Adjusted EBITDA improved to $9.7M from -$5.8M. Management highlighted projects like mechanical vapor recompression and LCFS pathway approvals, but noted risks from uncertain emissions rates and feedstock constraints.

$AMTXMed

Aemetis (AMTX) Q2 2026 Earnings Call Transcript

Aemetis (AMTX) Q2 2026 earnings call said consolidated revenue rose 20% year over year, operating income improved by $16.4 million, and adjusted EBITDA increased by $15.5 million versus Q2 2025. The company cited CARB approval of 7 LCFS pathways and pending approvals for 6 digesters, plus ethanol projects including a $32 million annual cash flow MVR system. India biodiesel revenue was $2.5 million, with expected $17 million from new allocations.

$AMTXMed

Aemetis Q2 2026 Earnings: Financial Results, Revenue, and Segment Performance Highlights – Minichart

Aemetis reported Q2 2026 revenue of $62.7 million, up $10.5 million (20%) from Q2 2025, including $8.6 million from Section 45Z tax credits. Operating income improved by $16.4 million, net loss narrowed to $9.4 million, and adjusted EBITDA rose to $9.7 million. The company is pursuing refinancing and financing for its Keyes ethanol and Dairy RNG projects, and is considering an IPO for its India unit.